Status:
COMPLETED
MonitAir Remote Patient Monitoring Versus Standard of Care for CPAP Adherence in Obstructive Sleep Apnea
Lead Sponsor:
MonitAir
Collaborating Sponsors:
BetterNight
Conditions:
Obstructive Sleep Apnea (OSA)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study tested whether using the MonitAir remote patient monitoring (RPM) platform could improve adherence to continuous positive airway pressure (CPAP) therapy for patients with obstructive sleep ...
Detailed Description
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder that is associated with hypertension, cardiovascular disease, diabetes, and impaired quality of life. Continuous positive airway pres...
Eligibility Criteria
Inclusion
- Adults ≥18 years old
- Access to a smartphone (iOS or Android)
- Ability to engage in two-way text communication and audiovisual conferencing
- Home sleep test (HST) or polysomnogram (PSG) performed ≤90 days before randomization
- Apnea-Hypopnea Index (AHI) ≥5 (using 3% desaturation criteria)
- Prescribed and willing to initiate CPAP or APAP therapy
- Receiving a ResMed, Philips, or React CPAP device with a cellular modem
- CPAP data available to MonitAir and BetterNight
Exclusion
- Department of Transportation (DOT) drivers
- Central sleep apnea or Cheyne-Stokes respirations (CSA/CSR) ≥10% of diagnostic study
- Central or mixed apneas ≥25% of AHI
- Use of BiPAP, BiPAP ST, ASV, AVAPS, or any other non-invasive ventilation modality
- Inability or unwillingness to participate in study activities or meet requirements
Key Trial Info
Start Date :
February 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07182617
Start Date
February 5 2024
End Date
April 1 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Remote
Miami, Florida, United States, 33176